Abstract
Unlike classical antidepressants, psychedelics such as psilocybin have been shown to induce a rapid antidepressant response. In the wake of this development, interest has emerged in ultra-fast, sho...
Cite
CITATION STYLE
APA
Ramaekers, J. G., Reckweg, J. T., & Mason, N. L. (2025). Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression. American Journal of Psychiatry, 182(1), 33–46. https://doi.org/10.1176/appi.ajp.20230890
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free